A 57-year-old man with type 2 diabetes and hypertension attends for cardiovascular risk assessment. He has no known atherosclerotic cardiovascular disease. His LDL-C is 3.6 mmol/L, HDL-C 1.0 mmol/L, triglycerides 1.8 mmol/L. According to the 2021 Canadian Cardiovascular Society dyslipidaemia guideline, which is the most appropriate lipid-lowering strategy?